Literature DB >> 949633

Chemotactic migration of leucocytes through corneal layers: an in vitro study.

P K Basu, J O Minta.   

Abstract

The ability of polymorphonuclear leucocytes (PMNs) to migrate into the different corneal layers in the presence or absence of a chemotactic stimulus was investigated in rabbits. The epithelial and/or endothelial surfaces were damaged in some corneas and in others they were intact. One side of the cornea was kept in contact with a viable population of rabbit PMNs and the other side with a chemotactic agent (zymosan activated human serum). The migration of PMNs into the cornea was traced histologically. The PMNs could not penetrate intact epithelium and Descemet's membrane even under the influence of a chemotactic stimulus. The stroma allowed PMN migration only when the chemotactic agent was present. The endothelium offered no resistance to PMN invasion whether the chemotactic stimulus was present or not.

Entities:  

Mesh:

Year:  1976        PMID: 949633

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


  4 in total

1.  Effect of hydrocortisone on the mobilisation of leucocytes in corneal wounds.

Authors:  P K Basu; M Avaria; R Jankie
Journal:  Br J Ophthalmol       Date:  1981-10       Impact factor: 4.638

2.  Experimental bacterial keratitis in neutropenic guinea pigs: polymorphonuclear leukocytes in corneal host defense.

Authors:  M J Chusid; S D Davis
Journal:  Infect Immun       Date:  1979-06       Impact factor: 3.441

3.  Demonstration of inflammatory mediator-induced inflammation and endothelial cell damage in the anterior segment of the eye.

Authors:  F N Rowland; M J Donovan; M Lindsay; W I Weiss; J O'Rourke; D L Kreutzer
Journal:  Am J Pathol       Date:  1983-01       Impact factor: 4.307

4.  Biocidal efficacy of multipurpose solutions against Gram-negative organisms associated with corneal infiltrative events.

Authors:  Denise Callahan; Christopher Kovacs; Shawn Lynch; Marjorie Rah
Journal:  Clin Exp Optom       Date:  2017-02-14       Impact factor: 2.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.